Srs Capital Advisors, Inc. Novo Nordisk A S Transaction History

Srs Capital Advisors, Inc.

$8.6 Billion
Q3 2025

A detailed history of Srs Capital Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 20,982 shares of NVO stock, worth $1.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,982

Previous 3,317 532.56%

Holding current value

$1.02 Million

Previous $228,000 410.53%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$45.38 - $71.7 $801,637 - $1.27 Million	17,665 Added 532.56%	20,982 $1.16 Million
Q2 2025 Aug 12, 2025	SELL	$58.08 - $81.05 $186,901 - $260,818	-3,218 Reduced 49.24%	3,317 $228,000
Q1 2025 May 14, 2025	SELL	$69.3 - $90.95 $96,257 - $126,329	-1,389 Reduced 17.53%	6,535 $453,000
Q4 2024 Feb 05, 2025	BUY	$85.0 - $120.04 $366,775 - $517,972	4,315 Added 119.56%	7,924 $681,000
Q3 2024 Nov 06, 2024	SELL	$119.07 - $145.42 $3,333 - $4,071	-28 Reduced 0.77%	3,609 $429,000

Q2 2024 Aug 06, 2024	SELL	$122.71 - $146.91 $19,388 - $23,211	-158 Reduced 4.16%	3,637 $519,000
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $18,686 - $24,873	-183 Reduced 4.6%	3,795 $487,000
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $148,260 - $178,105	1,689 Added 73.79%	3,978 $411,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $111,037 - $243,638	1,221 Added 114.33%	2,289 $208,000
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $1,247 - $1,381	8 Added 0.75%	1,068 $172,000
Q1 2023 May 16, 2023	BUY	$132.34 - $159.14 $12,307 - $14,800	93 Added 9.62%	1,060 $168,000
Q4 2022 Feb 24, 2023	SELL	$102.55 - $135.33 $1,845 - $2,435	-18 Reduced 1.83%	967 $130,000
Q3 2022 Nov 03, 2022	BUY	$95.28 - $116.93 $8,384 - $10,289	88 Added 9.81%	985 $98,000
Q2 2022 Aug 22, 2022	BUY	$103.24 - $121.81 $36,753 - $43,364	356 Added 65.8%	897 $100,000
Q1 2022 May 12, 2022	BUY	$93.1 - $112.54 $46,363 - $56,044	498 Added 1158.14%	541 $60,000
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $3,355 - $4,097	35 Added 437.5%	43 $5,000
Q3 2021 Nov 05, 2021	BUY	$84.42 - $106.62 $675 - $852	8 New	8 $1,000
Q2 2021 Aug 02, 2021	SELL	$67.66 - $84.76 $7,848 - $9,832	-116 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $63 - $70	1 Added 0.87%	116 $8,000
Q2 2020 Aug 06, 2020	BUY	$58.54 - $67.94 $58 - $67	1 Added 0.88%	115 $8,000
Q2 2019 Aug 08, 2019	BUY	$46.79 - $52.47 $93 - $104	2 Added 1.79%	114 $6,000
Q4 2018 Feb 06, 2019	SELL	$41.54 - $47.25 $3,198 - $3,638	-77 Reduced 40.74%	112 $5,000
Q3 2018 Nov 06, 2018	SELL	$46.76 - $51.24 $54,428 - $59,643	-1,164 Reduced 86.03%	189 $9,000
Q2 2018 Aug 21, 2018	SELL	$44.29 - $50.42 $1,948 - $2,218	-44 Reduced 3.15%	1,353 $62,000
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $176,988 - $212,211	-3,650 Reduced 72.32%	1,397 $68,000
Q4 2017 Feb 15, 2018	BUY	$47.53 - $53.73 $950 - $1,074	20 Added 0.4%	5,047 $270,000
Q3 2017 Nov 15, 2017	BUY	$41.15 - $49.22 $206,861 - $247,428	5,027	5,027 $242,000

Others Institutions Holding NVO

# of Institutions

1,697

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Novo Nordisk A S Transaction History